Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Trastuzumab-induced hepatotoxicity: a case report.

Vucicevic D, Carey EJ, Karlin NJ.

Breast Care (Basel). 2013 May;8(2):146-8. doi: 10.1159/000346844.

PMID:
24419371
[PubMed]
Free PMC Article
2.

Trastuzumab-induced hepatotoxicity.

Srinivasan S, Parsa V, Liu CY, Fontana JA.

Ann Pharmacother. 2008 Oct;42(10):1497-501. doi: 10.1345/aph.1L217. Epub 2008 Sep 9.

PMID:
18780811
[PubMed - indexed for MEDLINE]
3.

A case of HER-2-positive advanced inflammatory breast cancer with invasive micropapillary component showing a clinically complete response to concurrent trastuzumab and paclitaxel treatment.

Shigematsu H, Nakamura Y, Tanaka K, Shiotani S, Koga C, Kawaguchi H, Nishimura S, Taguchi K, Nishiyama K, Ohno S.

Int J Clin Oncol. 2010 Dec;15(6):615-20. doi: 10.1007/s10147-010-0093-2. Epub 2010 May 15.

PMID:
20473628
[PubMed - indexed for MEDLINE]
4.

Hepatotoxicity induced by trastuzumab used for breast cancer adjuvant therapy: a case report.

Ishizuna K, Ninomiya J, Ogawa T, Tsuji E.

J Med Case Rep. 2014 Dec 10;8:417. doi: 10.1186/1752-1947-8-417.

PMID:
25491149
[PubMed - in process]
Free PMC Article
5.

[Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].

Ohsako T, Inoue K, Nagamoto N, Yoshida Y, Nakahara O.

Gan To Kagaku Ryoho. 2006 Sep;33(9):1301-3. Japanese.

PMID:
16969029
[PubMed - indexed for MEDLINE]
6.

[Two cases of breast cancer responding to primary systemic chemotherapy containing trastuzumab without surgery].

Konishi K, Hasegawa N, Kaneko H, Iimura Y, Shoji Y, Kawabata M.

Gan To Kagaku Ryoho. 2010 Jan;37(1):115-8. Japanese.

PMID:
20087043
[PubMed - indexed for MEDLINE]
7.

Metastatic breast cancer of HER2 scored 2+ by IHC and HER2 gene amplification assayed by FISH has a good response to single agent therapy with trastuzumab: a case report.

Takahashi M, Inoue K, Goto R, Tamura M, Taguchi K, Takahashi H, Suzuki H, Katsushige K, Ogita M.

Breast Cancer. 2003;10(2):170-4.

PMID:
12736573
[PubMed - indexed for MEDLINE]
8.

A case of metastatic breast cancer with outgrowth of HER2-negative cells after eradication of HER2-positive cells by humanized anti-HER2 monoclonal antibody (trastuzumab) combined with docetaxel.

Kunitomo K, Inoue S, Ichihara F, Kono K, Fujii H, Matsumoto Y, Ooi A.

Hum Pathol. 2004 Mar;35(3):379-81.

PMID:
15017597
[PubMed - indexed for MEDLINE]
9.

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.

Gianni L, Eiermann W, Semiglazov V, Manikhas A, Lluch A, Tjulandin S, Zambetti M, Vazquez F, Byakhow M, Lichinitser M, Climent MA, Ciruelos E, Ojeda B, Mansutti M, Bozhok A, Baronio R, Feyereislova A, Barton C, Valagussa P, Baselga J.

Lancet. 2010 Jan 30;375(9712):377-84. doi: 10.1016/S0140-6736(09)61964-4.

PMID:
20113825
[PubMed - indexed for MEDLINE]
10.

[A case of effective trastuzumab plus gemcitabine therapy for human epidermal growth factor receptor 2-positive breast cancer].

Yabe N, Murai S, Shimizu H, Kitasato K, Yoshikawa T, Oto I, Nakadai J, Jinno H, Kitagawa Y.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2396-8. Japanese.

PMID:
24394124
[PubMed - indexed for MEDLINE]
11.

[Markedly effective regimen using bi-weekly trastuzumab and paclitaxel in an advanced breast cancer with multiple liver metastases].

Rai Y, Takahama T, Sagara Y, Sagara Y, Matsuyama Y, Ando M, Sagara Y, Ooi Y.

Gan To Kagaku Ryoho. 2006 Sep;33(9):1297-300. Japanese.

PMID:
16969028
[PubMed - indexed for MEDLINE]
12.

[A case of advanced breast cancer with multiple lung and liver metastases successfully treated with multi-disciplinary therapy].

Sakurai K, Enomoto K, Amano S, Kitajima A, Suzuki M, Matsuo S, Sakamoto A, Kashio M, Tani M, Negishi N.

Gan To Kagaku Ryoho. 2005 Oct;32(11):1792-4. Japanese.

PMID:
16315943
[PubMed - indexed for MEDLINE]
13.

[A case of HER2-positive metastatic breast cancer responding to trastuzumab plus gemcitabine combination therapy].

Sugie T, Nagai T, Ohgaki K.

Gan To Kagaku Ryoho. 2008 Apr;35(4):683-6. Japanese.

PMID:
18408445
[PubMed - indexed for MEDLINE]
14.

[Successful treatment of trastuzumab-resistant HER2-positive breast cancer with extensive liver metastases using the combination of trastuzumab and capecitabine - a case report].

Shigekawa T, Takeuchi H, Misumi M, Nakamiya N, Sugiyama M, Sugitani I, Fujiuchi N, Osaki A, Saeki T.

Gan To Kagaku Ryoho. 2013 Feb;40(2):225-7. Japanese.

PMID:
23411960
[PubMed - indexed for MEDLINE]
15.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Láng I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Rüschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gelber RD; Herceptin Adjuvant (HERA) Trial Study Team.

N Engl J Med. 2005 Oct 20;353(16):1659-72.

PMID:
16236737
[PubMed - indexed for MEDLINE]
Free Article
17.

Duration of anti-HER2 blockage therapy may improve survival in HER2 positive metastatic breast carcinoma patients.

Arslan UY, Turker I, Aksoy S, Oksuzoglu B, Helvaci K, Yildirim Ozdemir N, Uyeturk U, Uysal Sonmez O, Budakoglu B, Zengin N.

J BUON. 2013 Jul-Sep;18(3):585-93.

PMID:
24065468
[PubMed - indexed for MEDLINE]
18.

[A case of breast cancer liver metastases with jaundice responding to trastuzumab monotherapy].

Ueda H, Nakagawa T, Sato T, Nagahara M, Sugihara K.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2068-70. Japanese.

PMID:
23267979
[PubMed - indexed for MEDLINE]
19.

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer.

Goldenberg MM.

Clin Ther. 1999 Feb;21(2):309-18. Review.

PMID:
10211534
[PubMed - indexed for MEDLINE]
20.

Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the Literature.

Dumitrescu C, Lossignol D.

Case Rep Oncol Med. 2013;2013:154674. doi: 10.1155/2013/154674. Epub 2013 Jan 28.

PMID:
23424693
[PubMed]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk